Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gourdon

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Ultrasonics Sonochemistry|November 4, 2000
Emulsification processes: on-line study by multiple light scattering measurementsB Abismaïl, J P Canselier, A M Wilhelm, et al.
Ultrasonics Sonochemistry|March 10, 2001
Emulsification by ultrasound: drop size distribution and stabilityB Abismaïl, J P Canselier, A M Wilhelm, et al.
Revue Des Maladies Respiratoires|January 1, 1990
[Endobronchial aspergillosis associated with a carcinoid tumor]E Quoix, B Gasser, M Apprill, et al.
European Journal of Pharmacology|September 4, 2021
Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmosetImane Frouni, Sébastien Belliveau, Shawn Maddaford, et al.
Experimental Brain Research|November 17, 2018
5-HT<sub>2A</sub> blockade for dyskinesia and psychosis in Parkinson's disease: is there a limit to the efficacy of this approach? A study in the MPTP-lesioned marmoset and a literature mini-reviewCynthia Kwan, Imane Frouni, Dominique Bédard, et al.
Neuropharmacology|November 5, 2020
Selective blockade of the 5-HT<sub>3</sub> receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmosetCynthia Kwan, Stephen G Nuara, Dominique Bédard, et al.
Neuropharmacology|July 4, 2018
The highly selective 5-HT<sub>2A</sub> antagonist EMD-281,014 reduces dyskinesia and psychosis in the l-DOPA-treated parkinsonian marmosetAdjia Hamadjida, Stephen G Nuara, Dominique Bédard, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 5, 2020
Monoamine oxidase A inhibition with moclobemide enhances the anti-parkinsonian effect of L-DOPA in the MPTP-lesioned marmosetAdjia Hamadjida, Stephen G Nuara, Cynthia Kwan, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 2020
Monoamine oxidase A inhibition as monotherapy reverses parkinsonism in the MPTP-lesioned marmosetAdjia Hamadjida, Stephen G Nuara, Imane Frouni, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 5, 2020
Combined mGlu<sub>2</sub> orthosteric stimulation and positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the parkinsonian marmosetStephen G Nuara, Adjia Hamadjida, Cynthia Kwan, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Ultrasonics Sonochemistry|November 4, 2000
Emulsification processes: on-line study by multiple light scattering measurementsB Abismaïl, J P Canselier, A M Wilhelm, et al.
Ultrasonics Sonochemistry|March 10, 2001
Emulsification by ultrasound: drop size distribution and stabilityB Abismaïl, J P Canselier, A M Wilhelm, et al.
Revue Des Maladies Respiratoires|January 1, 1990
[Endobronchial aspergillosis associated with a carcinoid tumor]E Quoix, B Gasser, M Apprill, et al.
European Journal of Pharmacology|September 4, 2021
Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmosetImane Frouni, Sébastien Belliveau, Shawn Maddaford, et al.
Experimental Brain Research|November 17, 2018
5-HT<sub>2A</sub> blockade for dyskinesia and psychosis in Parkinson's disease: is there a limit to the efficacy of this approach? A study in the MPTP-lesioned marmoset and a literature mini-reviewCynthia Kwan, Imane Frouni, Dominique Bédard, et al.
Neuropharmacology|November 5, 2020
Selective blockade of the 5-HT<sub>3</sub> receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmosetCynthia Kwan, Stephen G Nuara, Dominique Bédard, et al.
Neuropharmacology|July 4, 2018
The highly selective 5-HT<sub>2A</sub> antagonist EMD-281,014 reduces dyskinesia and psychosis in the l-DOPA-treated parkinsonian marmosetAdjia Hamadjida, Stephen G Nuara, Dominique Bédard, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 5, 2020
Monoamine oxidase A inhibition with moclobemide enhances the anti-parkinsonian effect of L-DOPA in the MPTP-lesioned marmosetAdjia Hamadjida, Stephen G Nuara, Cynthia Kwan, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 2020
Monoamine oxidase A inhibition as monotherapy reverses parkinsonism in the MPTP-lesioned marmosetAdjia Hamadjida, Stephen G Nuara, Imane Frouni, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 5, 2020
Combined mGlu<sub>2</sub> orthosteric stimulation and positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the parkinsonian marmosetStephen G Nuara, Adjia Hamadjida, Cynthia Kwan, et al.
Pageof 5